| Improving the kinetic hydrate inhibition performance of 3-methylene-2-pyrrolidone polymers by n-alkylation, ring expansion, and copolymerization Q Zhang, IM Heyns, R Pfukwa, B Klumperman, MA Kelland Energy & Fuels 32 (12), 12337-12344, 2018 | 24 | 2018 |
| Synthesis, Characterization, and Evaluation of Cytotoxicity of Poly (3-methylene-2-pyrrolidone) IM Heyns, R Pfukwa, B Klumperman Biomacromolecules 17 (5), 1795-1800, 2016 | 18 | 2016 |
| First study of poly (3-methylene-2-pyrrolidone) as a kinetic hydrate inhibitor E Abrahamsen, IM Heyns, N von Solms, R Pfukwa, B Klumperman, ... Energy & Fuels 31 (12), 13572-13577, 2017 | 14 | 2017 |
| Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin IM Heyns, R Ganugula, T Varma, S Allamreddy, N Kumar, P Garg, ... ACS Applied Materials & Interfaces 15 (39), 45651-45657, 2023 | 8 | 2023 |
| Thermoresponsive behavior of poly (3-methylene-2-pyrrolidone) derivatives IM Heyns, R Pfukwa, L Bertossi, LE Ball, MA Kelland, B Klumperman European Polymer Journal 112, 714-721, 2019 | 7 | 2019 |
| Glucose-responsive microgel comprising conventional insulin and curcumin-laden nanoparticles: a potential combination for diabetes management IM Heyns, G Davis, R Ganugula, MNV Ravi Kumar, M Arora The AAPS Journal 25 (4), 72, 2023 | 3 | 2023 |
| Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein IM Heyns, M Arora, R Ganugula, SR Allamreddy, S Tiwari, DK Shah, ... ACS nano 18 (18), 11863-11875, 2024 | 2 | 2024 |
| Poly (3-methylene-2-pyrrolidone). Synthesis, characterization and evaluation of cytotoxicity IM Heyns, R Pfukwa, B Klumperman Biomacromolecules 17, 1795-1800, 2016 | 1 | 2016 |
| Nanoparticles with anti-inflammatory properties and enhanced penetration across the biological barriers to deliver encapsulated drugs R Majeti, M Arora, IM Heyns, R Ganugula US Patent App. 18/397,327, 2024 | | 2024 |
| Lymph node targeting of cyclosporine ameliorates ocular manifestations in a mouse model of systemic lupus erythematosus (SLE) via PD-L1 R Ganugula, KT Babalola, IM Heyns, M Arora, SK Agarwal, C Mohan, ... Nano Today 57, 102359, 2024 | | 2024 |
| Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction IM Heyns, AF Faunce, MN Mumba, MNVR Kumar, M Arora ACS Pharmacology & Translational Science 7 (8), 2237-2250, 2024 | | 2024 |
| The use of 3-methylene-2-pyrrolidone-based (co) polymers in industrial and biomedical applications IM Heyns Stellenbosch: Stellenbosch University, 2018, 2018 | | 2018 |
